Observational studyTherapeutic advances in cardiovascular disease

MiR-21 and Tocilizumab interactions improve COVID-19 myocarditis outcomes.

Amir Hossein Heydari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.